Growth Metrics

Bio-Rad Laboratories (BIO) Total Current Liabilities (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Total Current Liabilities for 17 consecutive years, with $517.0 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 10.52% to $517.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $517.0 million through Dec 2025, up 10.52% year-over-year, with the annual reading at $517.0 million for FY2025, 10.52% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $517.0 million at Bio-Rad Laboratories, down from $522.3 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $680.9 million in Q4 2021, with the low at $466.2 million in Q1 2024.
  • Average Total Current Liabilities over 5 years is $559.8 million, with a median of $563.4 million recorded in 2022.
  • The sharpest move saw Total Current Liabilities crashed 36.66% in 2021, then increased 12.72% in 2025.
  • Over 5 years, Total Current Liabilities stood at $680.9 million in 2021, then decreased by 16.48% to $568.7 million in 2022, then decreased by 8.07% to $522.8 million in 2023, then dropped by 10.52% to $467.8 million in 2024, then increased by 10.52% to $517.0 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $517.0 million, $522.3 million, and $548.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.